Rafarma Pharmaceuticals RAFA Stock
Rafarma Pharmaceuticals Price Chart
Rafarma Pharmaceuticals RAFA Financial and Trading Overview
| Rafarma Pharmaceuticals stock price | 0.12 USD |
| Previous Close | 0.29 USD |
| Open | 0.28 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.28 - 0.28 USD |
| 52 Week Range | 0.22 - 0.74 USD |
| Volume | 10.65K USD |
| Avg. Volume | 26.25K USD |
| Market Cap | 106.85M USD |
| Beta (5Y Monthly) | -0.514436 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.014 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RAFA Valuation Measures
| Enterprise Value | 2.35M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 801.3809 |
| Price/Book (mrq) | 0.0069158003 |
| Enterprise Value/Revenue | 17.637 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Rafarma Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | -0.514436 |
| 52-Week Change | -40.42% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.74 USD |
| 52 Week Low | 0.22 USD |
| 50-Day Moving Average | 0.32 USD |
| 200-Day Moving Average | 0.4 USD |
RAFA Share Statistics
| Avg. Volume (3 month) | 26.25K USD |
| Avg. Daily Volume (10-Days) | 16.49K USD |
| Shares Outstanding | 0 |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2012 |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | March 31, 2013 |
Profitability
| Profit Margin | -87.91% |
| Operating Margin (ttm) | -81.25% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -0.041% |
| Return on Equity (ttm) | -0.071% |
Income Statement
| Revenue (ttm) | 133.33K USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -117223 USD |
| Diluted EPS (ttm) | -0.014 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 40.487 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 25K USD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Rafarma Pharmaceuticals
| Country | United States |
| State | UT |
| City | Sandy |
| Address | 49 West 9000 South |
| ZIP | 84070 |
| Phone | 801-210-7135 |
| Website | https://rafarma.si |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders. The company has a collaboration agreement with PlantEXT Ltd. to research and manufacture the first medical cannabis suppositories for patients suffering from inflammatory bowel disease. Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012. The company is based in Sandy, Utah with a manufacturing and distribution facility in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd.
Q&A For Rafarma Pharmaceuticals Stock
What is a current RAFA stock price?
Rafarma Pharmaceuticals RAFA stock price today per share is 0.12 USD.
How to purchase Rafarma Pharmaceuticals stock?
You can buy RAFA shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Rafarma Pharmaceuticals?
The stock symbol or ticker of Rafarma Pharmaceuticals is RAFA.
Which industry does the Rafarma Pharmaceuticals company belong to?
The Rafarma Pharmaceuticals industry is Drug Manufacturers-Specialty & Generic.
How many shares does Rafarma Pharmaceuticals have in circulation?
The max supply of Rafarma Pharmaceuticals shares is 919.04M.
What is Rafarma Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Rafarma Pharmaceuticals PE Ratio is now.
What was Rafarma Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Rafarma Pharmaceuticals EPS is -0.014 USD over the trailing 12 months.
Which sector does the Rafarma Pharmaceuticals company belong to?
The Rafarma Pharmaceuticals sector is Healthcare.